Although most of the above-mentioned studies mainly focused on cancer-related changes in RNASET2 expression assessed at the RNA level, more recently, a post-transcriptional mechanism for RNASET2 downregulation in cancer cells was reported as well. The gene discussed is RNASET2; the disease is cancer.